TrialThe Journal of antimicrobial chemotherapy2022

An open randomized multicentre Phase 2 trial to assess the safety of DAV132 and its efficacy to protect gut microbiota diversity in hospitalized patients treated with fluoroquinolones.

Maria J G T Vehreschild et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.